Marc Goldberg is co-founder and Managing Partner of BioVentures Investors. He brings well over 30 years of managerial and investment experience in the healthcare sector.

Prior to joining BioVentures, Marc served as President and CEO of the Massachusetts Biotechnology Research Institute. Marc was Vice President, Finance and Corporate Development, CFO, and Treasurer at Safer, Inc., a developer and manufacturer of novel biopesticides and related products, and started his career at Genetics Institute, one of the earliest biotechnology research and development companies.

Marc co-founded and served as founding president of the Massachusetts Biotechnology Council in 1985, served four terms as President, and was a Director from inception until 1997. On his retirement from the Board, Governor Weld proclaimed March 18, 1997 as “Marc Goldberg Day” in Massachusetts.

Marc is a member of the Harvard Medical School Advisory Council on Discovery, serves as Chairman Emeritus of the Harvard Varsity Club and is a member of the Board of Directors for both Step by Step Supportive Services and the Richi Childhood Cancer Foundation. Marc currently serves on the Board of Directors for Endotronix, Verax Biomedical, POC Medical, Cardiosolutions, HydroCision, sGC Pharma and Rachiotek.

Marc earned his A.B. from Harvard College, his J.D. from Harvard Law School, and his M.B.A. from Harvard Business School.